Onoue T, Goto M, Wada E, Furukawa M, et al. Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial. PLoS One 2020;15:e0228004.
PMID: 31990936